00928.HK
King International Investment Limited
HKSE · Healthcare · Medical - Diagnostics & Research · HK
HKD 0.12
−0.83%Margins
Gross margin
20.7%
EBITDA margin
-6.1%
EBIT margin
-6.4%
Net margin
-24.8%
FCF margin
-7.3%
-19.1%
Return on equity
-11.8%
Return on assets
-4.8%
Return on invested capital
0.50x
Asset turnover
-HKD 13.4M
Cash from operations
HKD 0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026